EUVIMEDEUVIMED entdecken
Open Access

PARP4 ADP-ribosylates PIDD1 to complete a phospho/SUMO/PAR-ylation cascade that orchestrates PIDDosome assembly

Richa B Shah iD, Yuanyuan Li iD, Ashley Person, Léonie Frigon iD, Nina Ðukić iD, Ela Kini iD, Raymond Chen, John M Pascal iD, Michael S Cohen iD, Ivan Ahel iD, John D Haley iD, Samuel Sidi iD

Science Advances · 01.05.2026 · 12 (18)

DOI: 10.1126/sciadv.adz9284 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, erschienen am 01.05.2026. Verfasst von Richa B Shah und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Division of Hematology and Medical Oncology, Mount Sinai Tisch Cancer Center, Icahn School of Medicine at Mount Sinai, New Yo…. Hauptthemen laut MEDLINE: Poly(ADP-ribose) Polymerases, Death Domain Receptor Signaling Adaptor Proteins, ADP-Ribosylation, CRADD Signaling Adaptor Protein. Die Arbeit nennt 116 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Institutes of Health, New York Community Trust, Pershing Square Sohn Cancer Research Alliance.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Adenosine diphosphate (ADP) ribosylation (ADPr) regulates multiple stress responses, yet substrates in the apoptotic machinery remain elusive. We show that a single, DNA damage–induced ADPr event controls proapoptotic PIDDosome (PIDD1/RAIDD/caspase-2) formation in response to unresolved interstrand DNA cross-links (ICL). ADPr targets conserved E783 in the PIDD1 death domain (DD); is catalyzed by poly(ADP-ribose) polymerase 4 (PARP4), a phylogenetically orphan PARP of previously unknown function; is reversed by the ribosylhydrolase activity of PARP14; and is triggered by Ataxia Telangiectasia and RAD3-related (ATR) phosphorylation–induced, PIAS1-mediated SUMOylation of the PIDD1 DD, which enables PARP4 docking. PIDD1 ADPr is dispensable for the recruitments of RAIDD and caspase-2 but essential for the dimerization of the caspase. Hence, denying E783 ADPr spares the onset of PIDDosome assembly but blocks its completion, thus eliminating caspase-2 activation and ensuing apoptosis. Conversely, removal of PARP14 forces apoptosis, even in cells with tolerable damage. The data identify PARP4 as an ICL response effector and illuminate a three-step modification sequence of the PIDD1 DD that conducts PIDDosome assembly from initiation to completion.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Poly(ADP-ribose) PolymerasesDeath Domain Receptor Signaling Adaptor ProteinsADP-RibosylationCRADD Signaling Adaptor ProteinHumansCaspase 2DNA DamageApoptosisPhosphorylationCysteine Endopeptidases

Substanzen

Poly(ADP-ribose) PolymerasesCaspase 2Death Domain Receptor Signaling Adaptor ProteinsPIDD1 protein, humanPARP14 protein, humanCRADD Signaling Adaptor ProteinCRADD protein, humanCASP2 protein, humanCysteine Endopeptidases

Autor:innen und Institutionen

  • Department of Medicine, Division of Hematology and Medical Oncology, Mount Sinai Tisch Cancer Center, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Department of Cell, Developmental and Regenerative Biology, Graduate School of Biomedical Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Department of Chemical Physiology and Biochemistry, Oregon Health and Science University, Portland, OR, USA.
  • Department of Biochemistry and Molecular Medicine, Université de Montréal, Montréal, QC, Canada.
  • Sir William Dunn School of Pathology, University of Oxford, Oxford, UK.
  • Department of Pathology Stony Brook Cancer Center, Stony Brook University, Stony Brook, NY, USA.

ORCID-Profile: Richa B Shah, Yuanyuan Li, Léonie Frigon, Nina Ðukić, Ela Kini, John M Pascal, Michael S Cohen, Ivan Ahel, John D Haley, Samuel Sidi

Förderung

  • National Institutes of Health
  • New York Community Trust
  • Pershing Square Sohn Cancer Research Alliance
  • Canadian Institutes of Health Research
  • Biotechnology and Biological Sciences Research Council
  • Stony Brook Renaissance School of Medicine and Stony Brook Cancer Center

Zitieren

APA

Shah, R. B., Li, Y., Person, A., Frigon, L., Ðukić, N., Kini, E., Chen, R., Pascal, J. M., Cohen, M. S., Ahel, I., Haley, J. D., & Sidi, S. (2026). PARP4 ADP-ribosylates PIDD1 to complete a phospho/SUMO/PAR-ylation cascade that orchestrates PIDDosome assembly. Science Advances, 12(18). https://doi.org/10.1126/sciadv.adz9284

Vancouver

Shah RB, Li Y, Person A, Frigon L, Ðukić N, Kini E, et al. PARP4 ADP-ribosylates PIDD1 to complete a phospho/SUMO/PAR-ylation cascade that orchestrates PIDDosome assembly. Science Advances. 2026;12(18). doi:10.1126/sciadv.adz9284

BibTeX
@article{Shah2026,
  author = {Shah, Richa B and Li, Yuanyuan and Person, Ashley and Frigon, Léonie and Ðukić, Nina and Kini, Ela and Chen, Raymond and Pascal, John M and Cohen, Michael S and Ahel, Ivan and Haley, John D and Sidi, Samuel},
  title = {PARP4 ADP-ribosylates PIDD1 to complete a phospho/SUMO/PAR-ylation cascade that orchestrates PIDDosome assembly},
  journal = {Science Advances},
  year = {2026},
  volume = {12},
  number = {18},
  doi = {10.1126/sciadv.adz9284}
}
Kostenlos starten →